Rheumatology

NICE has issued final guidance recommending golimumab for the treatment of psoriatic arthritis.

FDA approved tablet provides a new treatment option for RA sufferers who may be at risk for upper gastrointestinal ulcers stemming from chronic NSAID use.

Researchers advise further studies and receiving calcium from food instead of supplements.

Latest plan to confront opioid misuse, abuse, and diversion calls for stepped-up education, monitoring, proper disposal, and enforcement efforts.

The FDA approved Actemra as a treatment for children two years of age and older with active Systemic Juvenile Idiopathic Arthritis.

Humira was found to be ineffective on twenty-eight percent of RA patients in a recent study

Researchers at Brigham and Women's Hospital report an injectable gel that could spell the future for treating inflammatory diseases

A study has identified a new treatment for the most common periodic fever disease in children.

According to many studies, prolonged use of TNFa in rheumatoid arthritis patients may decrease the possibility of developing insulin resistance

Therapies that target myofascial trigger points may be effective at reducing fibromyalgia-related pain.

Researchers discover a way to mimic the mechanism in the body which fights inflammation.

A recent study proved that rituximab paired with TNF inhibitors and MTX is ineffective at enhancing safety in RA patients.

Watch this video for a brief discussion of options for the medical management of gout pain.

The US Patent and Trademark Office has issued a composition-of-matter patent for the drug Synavive.

Prior to an FDA ban on unapproved colchicine products, the drugs cost $0.10 a pill. The only FDA-approved colchicine product costs $5 a pill.

Rheumatoid arthritis and other autoimmune diseases affect more than 50 million Americans. Coordinated care is the key to reducing direct and indirect costs.

Limited joint mobility (LJM) is a common complication of diabetes mellitus (DM). LJM often is characterized by hand stiffness, but other joints may be involved. The prayer and tabletop signs may be used to detect limitation of joint mobility in the hands.

The incidence of ankle fractures in the older patient population is rising. These fractures are characterized as fragility fractures associated with osteoporosis, but propensity for falls, increased weight, and polypharmacy may be bigger risk factors than poor bone quality.

Degenerative spondylolisthesis usually is asymptomatic but may be associated with symptomatic spinal stenosis. Because the latter often is detected by imaging studies in asymptomatic patients, clinical correlation between symptoms and imaging is critical.

Patients who improve their lifestyle and maintain a positive mindset before undergoing total joint replacement (TJR) surgery are more likely to have better functional outcomes than those who do not, according to several studies presented at the recent American Academy of Orthopaedic Surgeons (AAOS) annual meeting held in San Diego.

Benlysta (belimumab) has received FDA approval for the treatment of patients with active, autoantibody-positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and NSAIDs, the agency announced.

Anti–tumor necrosis factor α (anti–TNF-α) agents appear to improve inflammatory arthritis and disability in patients with systemic sclerosis (SSc). However, their utility for skin involvement is less certain.

After 12 weeks of therapy with methotrexate (MTX), a simple model using the C-reactive protein (CRP) level and swollen joint count (SJC) may be useful in indicating week 52 radiographic progression in patients with rheumatoid arthritis (RA).

The prevalence of moderate to severe knee osteoarthritis (OA) is high in middle-aged women. This high prevalence is corroborated by strong associations with abnormalities identified with the use of MRI in addition to radiography in patient assessment.

A responder index (RI), a composite measurement of face-valid and non-redundant clinical end points that assess aspects of disease, may help resolve some of the challenges associated with the selection and use of appropriate outcome measures for chronic low back pain (LBP).

Fewer than two-thirds of Medicare managed care patients with rheumatoid arthritis (RA) receive a disease-modifying antirheumatic drug (DMARD).

A new study suggests a correlation between Rheumatoid Arthritis (RA) and women who have a difficult time conceiving.

Researchers have developed a computerized instrument to assess RA and joint pain in patients.

An application for smartphones has been developed that will help patients and their doctors keep track of their rheumatoid arthritis.

Older patients taking bisphosphonates for bone metastases may have increased health risks